165 related articles for article (PubMed ID: 36839637)
1. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer.
Akkın S; Varan G; Işık A; Gökşen S; Karakoç E; Malanga M; Esendağlı G; Korkusuz P; Bilensoy E
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839637
[TBL] [Abstract][Full Text] [Related]
2. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU.
Akkın S; Varan G; Aksüt D; Malanga M; Ercan A; Şen M; Bilensoy E
Int J Pharm; 2022 Jul; 623():121940. PubMed ID: 35724824
[TBL] [Abstract][Full Text] [Related]
3. Tailoring biomimetic dual-redox-responsive nanoplexes for enhanced RNAi-synergized photodynamic cancer immunotherapy.
Fang Y; Chen S; Zhang M; Lin X; Jin X; Zhang M; Liu Y; Wang Y; Shi K
Acta Biomater; 2023 Feb; ():. PubMed ID: 36792046
[TBL] [Abstract][Full Text] [Related]
4. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
[No Abstract] [Full Text] [Related]
6. Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors.
Ünal S; Varan G; Benito JM; Aktaş Y; Bilensoy E
Beilstein J Org Chem; 2023; 19():139-157. PubMed ID: 36814451
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin.
Zhao N; Leng Q; Woodle MC; Mixson AJ
Biochem Biophys Res Commun; 2019 May; 513(1):242-247. PubMed ID: 30954222
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
Zhao L; Wang WJ; Zhang JN; Zhang XY
Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
12. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
[TBL] [Abstract][Full Text] [Related]
13. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
14. Green amorphous nanoplex as a new supersaturating drug delivery system.
Cheow WS; Hadinoto K
Langmuir; 2012 Apr; 28(15):6265-75. PubMed ID: 22439687
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes.
Abioye A; Sanyaolu A; Dudzinska P; Adepoju-Bello AA; Coker HAB
Pharm Nanotechnol; 2020; 8(1):33-53. PubMed ID: 31642799
[TBL] [Abstract][Full Text] [Related]
16. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Wang T; Zhang J; Hou T; Yin X; Zhang N
Nanoscale; 2019 Aug; 11(29):13934-13946. PubMed ID: 31305839
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
19. Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2012 Apr; 92():55-63. PubMed ID: 22154010
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]